Suppressive effect of 1,25-dihydroxyvitamin D3 and its analogues EB 1089 and KH 1060 on T lymphocyte proliferation in active ulcerative colitis (Q31923455)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Suppressive effect of 1,25-dihydroxyvitamin D3 and its analogues EB 1089 and KH 1060 on T lymphocyte proliferation in active ulcerative colitis	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

5 July 2017

Suppressive effect of 1,25-dihydroxyvitamin D3 and its analogues EB 1089 and KH 1060 on T lymphocyte proliferation in active ulcerative colitis (English)

1 reference

Europe PubMed Central

5 July 2017

1 reference

based on heuristic

inferred from title

author name string

Stio M

1

1 reference

Europe PubMed Central

5 July 2017

Bonanomi AG

2

1 reference

Europe PubMed Central

5 July 2017

d'Albasio G

3

1 reference

Europe PubMed Central

5 July 2017

Treves C

4

1 reference

Europe PubMed Central

5 July 2017

language of work or name

0 references

publication date

1 February 2001

1 reference

Europe PubMed Central

5 July 2017

Biochemical Pharmacology

1 reference

Europe PubMed Central

5 July 2017

61

1 reference

Europe PubMed Central

5 July 2017

3

1 reference

Europe PubMed Central

5 July 2017

365-371

1 reference

Europe PubMed Central

5 July 2017

The Vitamin D Endocrine System: Steroid Metabolism, Hormone Receptors, and Biological Response (Calcium Binding Proteins)*

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900564-5

7 January 2021

1 alpha,25-Dihydroxyvitamin D3 induces differentiation of human myeloid leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900564-5

7 January 2021

Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900564-5

7 January 2021

1,25-dihydroxyvitamin D3 inhibits proliferation of human promyelocytic leukaemia (HL60) cells and induces monocyte-macrophage differentiation in HL60 and normal human bone marrow cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900564-5

7 January 2021

Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900564-5

7 January 2021

Induction of monocytic differentiation and bone resorption by 1,25-dihydroxyvitamin D3.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900564-5

7 January 2021

1,25-Dihydroxyvitamin D3Receptors in Human Leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900564-5

7 January 2021

SPECIFIC HIGH-AFFINITY RECEPTORS FOR 1,25-DIHYDROXYVITAMIN D3IN HUMAN PERIPHERAL BLOOD MONONUCLEAR CELLS: PRESENCE IN MONOCYTES AND INDUCTION IN T LYMPHOCYTES FOLLOWING ACTIVATION

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900564-5

7 January 2021

1 alpha,25-Dihydroxyvitamin D3 inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900564-5

7 January 2021

Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900564-5

7 January 2021

EB1089: a new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900564-5

7 January 2021

Effects of 1,25 dihydroxyvitamin D3 and its analogues on induction of apoptosis in breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900564-5

7 January 2021

Vitamin D3 analogue (EB 1089) inhibits in vitro cellular proliferation of human colon cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900564-5

7 January 2021

A phase I study of the vitamin D analogue EB 1089 in patients with advanced breast and colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900564-5

7 January 2021

20-EPI-vitamin D3 analogues: A novel class of potent regulators of cell growth and immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900564-5

7 January 2021

Synergistic decrease of clonal proliferation, induction of differentiation, and apoptosis of acute promyelocytic leukemia cells after combined treatment with novel 20-epi vitamin D3 analogs and 9-cis retinoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900564-5

7 January 2021

Predicting therapeutic outcome in severe ulcerative colitis by measuring in vitro steroid sensitivity of proliferating peripheral blood lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900564-5

7 January 2021

Impaired mitogenic response of peripheral blood T cells in ulcerative colitis is not due to apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900564-5

7 January 2021

Immunologic mechanisms in intestinal diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900564-5

7 January 2021

The immunologic basis of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900564-5

7 January 2021

Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol)

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900564-5

7 January 2021

1,25-dihydroxyvitamin D3: a novel immunoregulatory hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900564-5

7 January 2021

Deficient interleukin 2 dependent proliferation pathway in T lymphocytes from active and inactive ulcerative colitis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900564-5

7 January 2021

The presence of Ia antigen on human peripheral blood T cells and T-cell subsets: analysis with monoclonal antibodies and the fluorescence-activated cell sorter

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900564-5

7 January 2021

Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900564-5

7 January 2021

Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900564-5

7 January 2021

Alterations of the immune system in ulcerative colitis and Crohn's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900564-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0006-2952(00)00564-5

1 reference

Europe PubMed Central

5 July 2017

1 reference

Europe PubMed Central

5 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31923455&oldid=1547892461"